KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Operating Margin: 2019-2025

Historic Operating Margin for Aurinia Pharmaceuticals (AUPH) over the last 5 years, with Sep 2025 value amounting to 40.49%.

  • Aurinia Pharmaceuticals' Operating Margin rose 2315.00% to 40.49% in Q3 2025 from the same period last year, while for Sep 2025 it was 26.34%, marking a year-over-year increase of 4117.00%. This contributed to the annual value of -1.99% for FY2024, which is 5025.00% up from last year.
  • Latest data reveals that Aurinia Pharmaceuticals reported Operating Margin of 40.49% as of Q3 2025, which was up 41.14% from 28.69% recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Operating Margin registered a high of 40.49% during Q3 2025, and its lowest value of -5,529.87% during Q1 2021.
  • Its 3-year average for Operating Margin is -11.90%, with a median of -2.79% in 2024.
  • The largest annual percentage gain for Aurinia Pharmaceuticals' Operating Margin in the last 5 years was 14,557,048bps (2021), contrasted with its biggest fall of 12,364bps (2021).
  • Quarterly analysis of 5 years shows Aurinia Pharmaceuticals' Operating Margin stood at -139.74% in 2021, then skyrocketed by 4,092bps to -98.82% in 2022, then soared by 3,302bps to -65.80% in 2023, then spiked by 6,302bps to -2.79% in 2024, then skyrocketed by 2,315bps to 40.49% in 2025.
  • Its Operating Margin stands at 40.49% for Q3 2025, versus 28.69% for Q2 2025 and 34.97% for Q1 2025.